FilingReader Intelligence

Yichang HEC shareholders approve Sunshine Lake privatisation deal

July 21, 2025 at 05:01 PM UTC•By FilingReader AI

Shareholders of Yichang HEC ChangJiang Pharmaceutical approved the privatisation by Sunshine Lake Pharma with over 99% support. The deal includes a special dividend of HK$1.50 per share.

The company will withdraw from the Stock Exchange by August 5, with new share dealings starting August 7.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

Primary Source Document

JOINT ANNOUNCEMENT (1) POLL RESULTS OF THE EGM AND THE H SHAREHOLDERS' CLASS MEETING HELD ON MONDAY, 21 JULY 2025 RELATING TO THE PROPOSED CONDITIONAL PRIVATISATION OF YICHANG HEC CHANGJIANG PHARMACEUTICAL CO., LTD. BY SUNSHINE LAKE PHARMA CO., LTD. BY WAY OF MERGER BY ABSORPTION OF YICHANG HEC CHANGJIANG PHARMACEUTICAL CO., LTD. (2) PROPOSED WITHDRAWAL OF LISTING AND LAST DAY OF TRADING (3) PROPOSED SPECIAL DIVIDEND AND (4) INFORMATION REGARDING EXERCISE OF RIGHT OF DISSENTING SHAREHOLDERSJuly 21, 2025 at 10:03 AM UTC

Yichang HEC ChangJiang Pharmaceutical

HKEX:1558•Hong Kong Exchange

RSS feed for Yichang HEC ChangJiang Pharmaceutical

News Alerts

Get instant email alerts when Yichang HEC ChangJiang Pharmaceutical publishes news

Free account required • Unsubscribe anytime

Browse RSS Feeds

Filing Activity Timeline

View Complete Filing History →